The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Genomic signatures to guide the use of chemotherapeutics
Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1491 · Cited by 593
RetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,193
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
Molecular machinery for non-vesicular trafficking of ceramide
Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., & Nishijima, M. (2003) · Nature · doi:10.1038/nature02188 · Cited by 1,051
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Self-citationShin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
Ein-Dor, L., Zuk, O., & Domany, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601231103 · Cited by 689
MacKeigan, J. P., Murphy, L. O., & Blenis, J. (2005) · Nature Cell Biology · doi:10.1038/ncb1258 · Cited by 561
Kops, G. J. P. L., Foltz, D. R., & Cleveland, D. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401142101 · Cited by 437
Regulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines
Shi, Q., & King, R. W. (2005) · Nature · doi:10.1038/nature03958 · Cited by 394
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Powell, D. J., Hajduch, E., Kular, G., & Hundal, H. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7794-7808.2003 · Cited by 370
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
Genome-wide survey of protein kinases required for cell cycle progression
Bettencourt-Dias, M., Giet, R., Sinka, R., Mazumdar, A., Lock, W. G., Balloux, F., Zafiropoulos, P. J., Yamaguchi, S., Winter, S., Carthew, R. W., et al. (2004) · Nature · doi:10.1038/nature03160 · Cited by 345
Ceramide synthesis and metabolism as a target for cancer therapy
Reynolds, C. P., Maurer, B. J., & Kolesnick, R. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.034 · Cited by 328
Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets
Eggert, U. S., Kiger, A. A., Richter, C., Perlman, Z. E., Perrimon, N., Mitchison, T. J., & Field, C. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020379 · Cited by 325
Karyotypic complexity of the NCI-60 drug-screening panel.
Roschke, A. V., Tonon, G., Gehlhaus, K., Mctyre, N., Bussey, K. J., Lababidi, S., Scudiero, D. A., Weinstein, J. N., & Kirsch, I. R. (2003) · PubMed · Cited by 316
Ceramide glycosylation potentiates cellular multidrug resistance
LIU, Y., HAN, T., GIULIANO, A. E., & CABOT, M. C. (2001) · The FASEB Journal · doi:10.1096/fj.00-0223com · Cited by 303
Watton, S. J., & Downward, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80192-4 · Cited by 293
Self-citationActivation of Akt/Protein Kinase B Overcomes a G 2 /M Cell Cycle Checkpoint Induced by DNA Damage
Kandel, E. S., Skeen, J., Majewski, N., Di Cristofano, A., Pandolfi, P. P., Feliciano, C. S., Gartel, A., & Hay, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7831-7841.2002 · Cited by 278
CERT Mediates Intermembrane Transfer of Various Molecular Species of Ceramides
Kumagai, K., Yasuda, S., Okemoto, K., Nishijima, M., Kobayashi, S., & Hanada, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409290200 · Cited by 236
Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability
Shin, H.-J., Baek, K.-H., Jeon, A.-H., Park, M.-T., Lee, S.-J., Kang, C.-M., Lee, H.-S., Yoo, S.-H., Chung, D.-H., Sung, Y.-C., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00302-7 · Cited by 172
Le, X., Pruefer, F., & Bast, R. C. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1360 · Cited by 170
Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy
Vogel, C., Kienitz, A., Hofmann, I., Müller, R., & Bastians, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207860 · Cited by 168
Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
STRATFORD, S., DEWALD, D. B., & SUMMERS, S. A. (2001) · Biochemical Journal · doi:10.1042/bj3540359 · Cited by 161
Gouazé, V., Liu, Y.-Y., Prickett, C. S., Yu, J. Y., Giuliano, A. E., & Cabot, M. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2329 · Cited by 158
Development of polyploidization in taxol-resistant human leukemia cells in vitro.
Roberts, J. R., Allison, D. C., Donehower, R. C., & Rowinsky, E. K. (1990) · PubMed · Cited by 100
Genomics in breast cancer—therapeutic implications
Lønning, P. E., Sørlie, T., & Børresen‐Dale, A. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0072 · Cited by 59
Prolonged Mitosis Versus Tetraploid Checkpoint: How p53 Measures the Duration of Mitosis
Blagosklonny, M. V. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2711 · Cited by 59
Alaoui‐Jamali, M. A., DUPRE, I., & Qiang, H. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.06.004 · Cited by 44
Jin, J., & Woodgett, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208704 · Cited by 30
Cited by
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
The Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
Genetic prognostic and predictive markers in colorectal cancer
Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I., & Kerr, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2645 · Cited by 705
Self-citationSalazar, M., Carracedo, A., Salanueva, Í. J., Hernández-Tiedra, S., Lorente, M., Egia, A., Vázquez, P., Blázquez, C., Torres, S., García, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37948 · Cited by 686
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kitatani, K., Idkowiak-Baldys, J., & Hannun, Y. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.006 · Cited by 632
Metadata
- Authors
- Swanton, C., Marani, M., Pardo, O., Warne, P. H., Kelly, G., Sahai, E., Elustondo, F., Chang, J., Temple, J., Ahmed, A. A., Brenton, J. D., Downward, J., & Nicke, B.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 11
- Issue
- 6
- Pages
- 498-512
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2036292773
- Cited by
- 381
- References
- 41
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.